Lenvatinib Mesylate and Verapamil Extended Release Tablets
Determining the interaction of Lenvatinib Mesylate and Verapamil Extended Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Verapamil Hydrochloride
- Lenvatinib Mesylate-Verapamil Hydrochloride PM
- Lenvatinib Mesylate-Verapamil Immediate-Release Tablets
- Lenvatinib Mesylate-Verapamil Injection
- Lenvatinib Mesylate-Verapamil Intravenous
- Lenvatinib Mesylate-Verapamil Long-Acting Capsules
- Verapamil Extended Release Tablets-Lenvima
- Verapamil Extended Release Tablets-Lenvima (14 MG Daily Dose)
- Verapamil Extended Release Tablets-Lenvima (18 MG Daily Dose)
- Verapamil Extended Release Tablets-Lenvima (20 MG Daily Dose)
- Verapamil Extended Release Tablets-Lenvima (24 MG Daily Dose)
- Verapamil Extended Release Tablets-Lenvima (8 MG Daily Dose)